Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study

LK Nielsen, C Stege, B Lissenberg-Witte, Ronnie van der Holt, UH Mellqvist, M Salomo, G Bos, MD Levin, Heleen Visser - Wisselaar, M Hansson, A van der Velden, W Deenik, J Coenen, M Hinge, S Klein, B Tanis, D Szatkowski, R Brouwer, M Westerman, R LeysH Sinnige, E Haukas, K van der Hem, M Durian, P Gimsing, N van de Donk, Pieter Sonneveld, A Waage, N Abildgaard, S Zweegman

Research output: Contribution to journalArticleAcademicpeer-review

22 Citations (Scopus)
18 Downloads (Pure)
Original languageEnglish
Pages (from-to)1650-1659
Number of pages10
JournalHaematologica
Volume105
Issue number6
DOIs
Publication statusPublished - 2020

Research programs

  • EMC OR-01

Cite this